Trial intelligence / Profile preview

Ceftaroline vs Linezolid in cSSSI

NCT00633152Phase 2Completed

Sponsor
Forest Laboratories
Start
Feb 2008
Primary completion
Jul 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of ceftaroline fosamil in Skin and Skin Structure Infection (SSSI), sponsored by Forest Laboratories. Started Feb 2008; status: completed.

02

Drugs

ceftaroline fosamil
03

Conditions

Skin and Skin Structure Infection (SSSI)

Beyond the preview

Go deeper on NCT00633152.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00633152.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call